Bristol-Myers Squibb discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs.
| Website: | www.bms.com |
| Email: | john.elicker@bms.com |
| Main Phone: | +1 212 546-4000 |
| Address: | 345 Park Avenue |
| State: | NY |
| City / Town: | New York |
| Country: | USA |
| Postal Code: | 10154 |
| Exchange: | NYE |
| CEO: | Giovanni Caforio |
| Employees: | 23700 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 51.05 | Change $ -1.07 | Change % -2.05 | Tick N/A |
| Bid 51.03 | Bid Size 600.00 | Ask 51.04 | Ask Size 100.00 |
| Open 51.93 | High 52.44 | Low 50.95 | Prev Close 52.12 |
| Last Trade | Volume 6.3 mi | 52 Wk Hi 70.05 | 52 Wk Low 46.94 |
| Market Cap 83.3 bi | Ex-Div Date | Div Rate 1.64 | Yield 3.1470 |
| Shares 1,632,198,774.00 | EPS (TTM) 0.89 | PE Ratio 58.60 | Exchange NYSE |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 9 | 156 |
| Number of Buys | 5 | 95 |
| Number of Sells | 4 | 61 |
| Net Activity | 14249 | 331983 |
| Last 10 Buys | Shares |
|---|---|
| Dinesh C. Paliwal | 1,000 |
| Theodore R. Samuels | 1,000 |
| Theodore R. Samuels | 1,000 |
| Theodore R. Samuels | 1,000 |
| James M. Cornelius | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Thomas J. Lynch | 1,000 |
| Sandra Leung | 1,000 |
| Joseph C. Caldarella | 1,000 |
| Lamberto Andreotti | 1,000 |
| Lamberto Andreotti | 1,000 |
| Lamberto Andreotti | 1,000 |
| Lamberto Andreotti | 1,000 |
| Louis S. Schmukler | 1,000 |
| Joseph C. Caldarella | 1,000 |
| Louis S. Schmukler | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 72 | 72 | 72 | 72 |
| Low Target Price Estimate | 47 | 47 | 47 | 47 |
| Mean Target Price Estimate | 60.55 | 60.91 | 60.91 | 60.55 |
| Standard Deviation | 7.88 | 8.19 | 8.19 | 7.88 |
| Date of Most Recent Estimate | 06/05/18 | 05/23/18 | 05/14/18 | 06/11/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 11-K | An annual report of employee stock purchase savings and similar plans | 16 | 2018-05-22 |
| 11-K | An annual report of employee stock purchase savings and similar plans | 16 | 2018-05-22 |
| 11-K | An annual report of employee stock purchase savings and similar plans | 16 | 2018-05-22 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-08 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-05-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-02 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 45 | 2018-04-26 |
| 8-K | Report of unscheduled material events or corporate changes. | 27 | 2018-04-26 |
| DEFA14A | Additional proxy soliciting materials - definitive | 15 | 2018-04-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-05 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 7 |
| Moderate Buy | 0 | 0 | 1 | 1 |
| Hold | 8 | 7 | 6 | 6 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 1 | 1 |
| Mean Rec. | 2.23 | 2.08 | 2.18 | 2.1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
